NRCAM and liver cancer: Furthermore, in liver cancer stem cells, neuronal cell adhesion molecule (NRCAM) mediates β-catenin signaling to activate EMT via MACF1.[40] Further investigations are warranted to explore its potential as a therapeutic target for inhibiting HCC cell migration and EMT.